Equitable Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Equitable Holdings, Inc.

$9.9 Billion
Q3 2024

A detailed history of Equitable Holdings, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Equitable Holdings, Inc. holds 1,106 shares of REGN stock, worth $816,228. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,106

Previous 1,075 2.88%

Holding current value

$816,228

Previous $1.13 Million 2.92%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $31,746 - $37,254	31 Added 2.88%	1,106 $1.16 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $48,576 - $58,915	55 Added 5.39%	1,075 $1.13 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $26,178 - $28,807	29 Added 2.93%	1,020 $981,000
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $23,255 - $26,451	30 Added 3.12%	991 $870,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $18,696 - $22,797	-27 Reduced 2.73%	961 $790,000
Q2 2023 Aug 15, 2023	BUY	$700.03 - $830.35 $14,700 - $17,437	21 Added 2.17%	988 $709,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $9,526 - $11,577	14 Added 1.47%	967 $794,000
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $220,237 - $239,113	312 Added 48.67%	953 $687,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $21,236 - $26,799	-37 Reduced 5.46%	641 $442,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $24,675 - $33,247	-45 Reduced 6.22%	678 $401,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $430,271 - $504,964	723 New	723 $505,000
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $248,913 - $307,304	-458 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $262,905 - $311,879	458 New	458 $277,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Equitable Holdings, Inc. with notifications on news.

Account

Equitable Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History